secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2021-09-24T23:59:59+00:00
Accession:  0001104659-21-119084
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Biostage loses product liability insurance coverage for wrongful death lawsuit; insurer files declaratory judgment
--------------------------------------------------------------------------------

- On Sept 15, 2021, a product liability insurer denied coverage for the 2017 wrongful death suit and will stop defending after Sept 30, 2021.
- Insurer filed a declaratory judgment complaint asking the court to rule no duty to defend, indemnify, or cover Biostage or Harvard Bioscience.
- Company intends to vigorously defend the insurance coverage denial and the underlying case; previous sanctions were vacated on Aug 6, 2021.
- If Biostage loses on merits and insurance does not cover, it may be forced to curtail or cease operations due to financial impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000110465921119084/0001104659-21-119084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000110465921119084/tm2128383-1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-119084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer